These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5017517)

  • 1. [Guancydine. Clinical evaluation of a new hypotensive agent].
    da Silva JA; Antunes NM; Laraia Cde B; Fraga Filho C
    Rev Bras Med; 1972 Jan; 29(1):42-7. PubMed ID: 5017517
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical assessment of the new antihypertensive Compound--1029 (Vatensol)--Guanoclor.
    Mehta AB; Biswas AK; Pinto IJ; Sheth UK
    Indian Heart J; 1967 Oct; 19(4):322-8. PubMed ID: 4870898
    [No Abstract]   [Full Text] [Related]  

  • 3. Guancydine, a new hypotensive agent with complex action.
    Hărăgus ST; Uza G; Duncea C
    Cor Vasa; 1977; 19(3):214-9. PubMed ID: 562730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
    Schäfer N; Knaup G
    Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further observations on a new antihypertensive Vatensol (Compound 1029).
    Srivastava BN; Vyas GP; Tiwari AK; Tapa RS; Nema HS
    Indian Heart J; 1967 Oct; 19(4):329-35. PubMed ID: 4870899
    [No Abstract]   [Full Text] [Related]  

  • 7. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
    Jiménez Casado M; Canto J; Yapur H; Oller JM
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
    [No Abstract]   [Full Text] [Related]  

  • 8. [A clinical trial of guanoxabenz: a hypotensive agent with central and hypertensive action (author's transl)].
    Ledoux F; Welsch M; Steimer C; Schwartz J
    Therapie; 1981; 36(2):187-91. PubMed ID: 7027519
    [No Abstract]   [Full Text] [Related]  

  • 9. Study of a new antihypertensive (guanabenz).
    McMahon FG; Cole PA; Boyles PW; Vanov SK
    Curr Ther Res Clin Exp; 1974 May; 16(5):389-97. PubMed ID: 4209126
    [No Abstract]   [Full Text] [Related]  

  • 10. [Animal experiment and clinical studies on the action mechanism of the antihypertensive agent guancydine].
    Werning C; Vetter W; Schweikert HU; Armbruster H; Fischer N; Trübestein G; Siegenthaler W
    Verh Dtsch Ges Inn Med; 1971; 77():1004-8. PubMed ID: 5170618
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study and evaluation of a new guanidine derivative: "Ciclazenine" in the therapy of arterial hypertension].
    Del Guercio R; Valva M; Conti G; Savarese A; Piemontese M
    Rass Int Clin Ter; 1969 May; 49(10):591-604. PubMed ID: 5784806
    [No Abstract]   [Full Text] [Related]  

  • 12. Guancydine, a new type of antihypertensive agent: a preliminary communication.
    Freis ED; Hammer J
    Med Ann Dist Columbia; 1969 Feb; 38(2):69-72. PubMed ID: 4884334
    [No Abstract]   [Full Text] [Related]  

  • 13. Guanfacine: a new centrally-acting antihypertensive agent.
    Beevers DG; Bloxham CA; Walker JM
    Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trial of a new antihypertensive agent associating Guanoxan sulfate with a thiazide diuretic].
    Linquette M; May JP; Cappoen JP
    Lille Med; 1972 Feb; 17():Suppl 2:183-6. PubMed ID: 5034400
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of a new antihypertensive combination (cyclazenine + presinol)].
    Ambrosioni E
    G Clin Med; 1967 Nov; 48(11):1149-62. PubMed ID: 5617984
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
    Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G
    Arzneimittelforschung; 1980; 30(6):1005-7. PubMed ID: 6998487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic trials with the new antihypertensive agent Tadip].
    Stein G
    Med Klin; 1968 Sep; 63(37):1466-8. PubMed ID: 5730203
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new antihypertensive agent used in a clinical setting].
    Wetzels E; Raschig A; Kaiser HJ
    Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanadrel (Hylorel)--a new antihypertensive drug.
    Med Lett Drugs Ther; 1983 Oct; 25(646):95-6. PubMed ID: 6621504
    [No Abstract]   [Full Text] [Related]  

  • 20. [The broad-spectrum antihypertensive agent Tadip in slight and moderate hypertension].
    Kempf E
    Med Monatsschr; 1968 Jun; 22(6):270-5. PubMed ID: 5720912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.